Bdh Industries Ltd
Fundamental Score
Bdh Industries Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of BDH across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Excellent ROCE Performance (17.82%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 21.89 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Strong Revenue Growth (16.82%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (221.33x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
3 factors identified
Limited Growth History (2.26% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Limited Institutional Interest (FII+DII: 0.28%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Bdh Industries Ltd
About BDH
Business Overview
BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, and pharmaceutical aid products. In addition, it provides skin protectives, skin smoothners, and vitamins, as well as SOULFIL, an oral pill for the treatment of erectile dysfunction in men. Further, the company is involved in the operation in renewable energy through two wind turbines with a total capacity of 0.8 MW located at Jaisalmer, Rajasthan. BDH Industries Limited was founded in 1935 and is based in Mumbai, India.
Company Details
Key Leadership
Corporate Events
BDH Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Bdh Industries Ltd (BDH)?
As of 21 Jan 2026, 08:47 am IST, Bdh Industries Ltd (BDH) is currently trading at ₹400.00. The stock has a market capitalization of ₹213.46 (Cr).
Is BDH share price Overvalued or Undervalued?
BDH is currently trading at a P/E ratio of 21.89x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Bdh Industries Ltd share price?
Key factors influencing BDH's price include its quarterly earnings growth (Sales Growth: 16.82%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Bdh Industries Ltd a good stock for long-term investment?
Bdh Industries Ltd shows a 5-year Profit Growth of 9.31% and an ROE of 14.16%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Bdh Industries Ltd compare with its industry peers?
Bdh Industries Ltd competes with major peers in the Pharmaceuticals. Investors should compare BDH's P/E of 21.89x and ROE of 14.16% against the industry averages to determine its competitive standing.
What is the P/E ratio of BDH and what does it mean?
BDH has a P/E ratio of 21.89x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹22 for every ₹1 of annual earnings.
How is BDH performing according to Bull Run's analysis?
BDH has a Bull Run fundamental score of 53.8/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does BDH belong to?
BDH operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Bdh Industries Ltd.
What is Return on Equity (ROE) and why is it important for BDH?
BDH has an ROE of 14.16%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Bdh Industries Ltd generates profits from shareholders' equity.
How is BDH's debt-to-equity ratio and what does it indicate?
BDH has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is BDH's dividend yield and is it a good dividend stock?
BDH offers a dividend yield of 1.21%, which means you receive ₹1.21 annual dividend for every ₹100 invested.
How has BDH grown over the past 5 years?
BDH has achieved 5-year growth rates of: Sales Growth 2.26%, Profit Growth 9.31%, and EPS Growth 9.31%.
What is the promoter holding in BDH and why does it matter?
Promoters hold 49.70% of BDH shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is BDH's market capitalization category?
BDH has a market capitalization of ₹213 crores, placing it in the Small-cap category.
How volatile is BDH stock?
BDH has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for BDH?
BDH has a 52-week high of ₹N/A and low of ₹N/A.
What is BDH's operating profit margin trend?
BDH has a 5-year average Operating Profit Margin (OPM) of 14.87%, indicating the company's operational efficiency.
How is BDH's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 16.82% and YoY Profit Growth of 8.71%.
What is the institutional holding pattern in BDH?
BDH has FII holding of 0.28% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.